Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some extracts from the Cohen Report

Re: @d2006s: gcduck

in response to by
posted on Jan 06, 2009 08:19AM

I know that PTSC just cannot project what the true revenues will be from the MMP because of the nature of IP licensing.

This projection by Cohen could have been done by me, you or anyone following this story but I don't put too much stock in this number because we simply do not know what will happen "when" we get the long awaited re cert for the 336.

I bought this stock because I believed (and still do) in the 336 technology being a CORE tech. in all things digital operating over 115 mghtz....sp??

I also remain "hopeful" that the projected 20 million a year from the MMP will be a lot higher than this with the 336 coming through with all its' teeth.

Let's get this SP up over $1 again upon the 336 re cert coming out!!!

Just my humble opinion and my constant optimism. Sorry if there are some that don't like rose colored glasses.



Share
New Message
Please login to post a reply